Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
1.960
+0.020 (1.03%)
At close: Nov 13, 2026, 4:00 PM EST
1.850
-0.110 (-5.61%)
After-hours: Nov 13, 2026, 4:15 PM EST
Atossa Therapeutics Market Cap
Atossa Therapeutics has a market cap or net worth of $19.56 million as of November 13, 2026. It is the 36,898th most valuable company in the world and the 5,161st biggest in the United States. Its market cap has decreased by 81.39% in one year.
Market Cap
19.56M
Enterprise Value
-1.01M
1-Year Change
-81.39%
Global Rank
Country Rank
#5,161 United States
Category
ChartMarket Cap Chart
Since November 8, 2012, Atossa Therapeutics's market cap has decreased from $62.00M to $19.56M, a decrease of -68.45%. That is a compound annual growth rate of -7.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 19.60M | -74.28% |
| Dec 31, 2025 | 76.20M | -35.86% |
| Dec 31, 2024 | 118.80M | 7.71% |
| Dec 29, 2023 | 110.30M | 64.87% |
| Dec 30, 2022 | 66.90M | -66.98% |
| Dec 31, 2021 | 202.60M | 197.94% |
| Dec 31, 2020 | 68.00M | 375.52% |
| Dec 31, 2019 | 14.30M | 146.55% |
| Dec 31, 2018 | 5.80M | -17.14% |
| Dec 29, 2017 | 7.00M | 32.08% |
| Dec 30, 2016 | 5.30M | -45.36% |
| Dec 31, 2015 | 9.70M | -72.36% |
| Dec 31, 2014 | 35.10M | -16.03% |
| Dec 31, 2013 | 41.80M | -17.06% |
| Dec 31, 2012 | 50.40M | -18.71% |
| Nov 8, 2012 | 62.00M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CEL-SCI | 22.51M |
| Estrella Immunopharma | 22.36M |
| TransCode Therapeutics | 22.35M |
| Filana Therapeutics | 21.37M |
| Celularity | 20.45M |
| BioStem Technologies | 19.51M |
| Lipocine | 18.94M |
| Cocrystal Pharma | 18.88M |